Gene expression profiling in multiple myeloma cells treated with the novel anti-myeloma agents zoledronate and fluvastatin.

被引：0
|
作者：
Molloy, TJ
Cindy, BB
Deng, YM
Spencer, A
Ma, DF
机构：
[1] Alfred Hosp, Myeloma Res Grp, Melbourne, Vic, Australia
[2] St Vincents Hosp, Sydney, NSW 2010, Australia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5078
引用
收藏
页码：351B / 351B
页数：1
相关论文
共 50 条
  • [41] Gene Expression Profiling to Predict Prognostic Biomarkers for Relapse in Multiple Myeloma
    Elahi, Sana
    Fazal, Sahar
    ADVANCEMENTS IN LIFE SCIENCES, 2024, 11 (02): : 329 - 337
  • [42] GENE EXPRESSION PROFILING OF MULTIPLE MYELOMA: IMPLICATIONS FOR A MOLECULAR CLASSIFICATION OF THE DISEASE
    Todoerti, K.
    Agnelli, L.
    Fabris, S.
    Verdelli, D.
    Nobili, L.
    Ciceri, G.
    Baldini, L.
    Morabito, F.
    Callea, V
    Palumbo, A.
    Deliliers, Lambertenghi G.
    Lombardi, L.
    Neri, A.
    HAEMATOLOGICA, 2008, 93 : S30 - S30
  • [43] Integrating cytogenetics and gene expression profiling in the molecular analysis of Multiple Myeloma
    John D. Shaughnessy
    Bart Barlogie
    International Journal of Hematology, 2002, 76 : 59 - 64
  • [44] Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma
    Shaughnessy, JD
    Barlogie, B
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 59 - 64
  • [45] HUMAN HERPESVIRUS 6 IS A FREQUENT INFECTION IN MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION IN THE ERA OF NOVEL ANTI-MYELOMA AGENTS
    Horowitz, N.
    Lavi, N.
    Zuckerman, T.
    Benyamini, N.
    Oren, I.
    Kra-Oz, Z.
    Held, V.
    Avivi, I.
    HAEMATOLOGICA, 2012, 97 : 397 - 397
  • [46] Gene expression profiling based on microarray among monoclonal gammopathy of undetermined significance, smoldering multiple myeloma and multiple myeloma
    Feng, Baotong
    Ding, Butong
    Sun, Yao
    Guo, Nongjian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 767 - 773
  • [47] Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: Possible anti-myeloma mechanism of thalidomide
    Iguchi, Toyotaka
    Yachide-Noguch, Tomomi
    Hashimoto, Yuichi
    Nakazato, Sawako
    Sagawa, Morihiko
    Ikeda, Yasuo
    Kizaki, Masahiro
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2008, 21 (02) : 163 - 168
  • [48] Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells
    Logie, Emilie
    Novo, Claudina Perez
    Driesen, Amber
    Van Vlierberghe, Pieter
    Vanden Berghe, Wim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [49] Dendritic cells present antigens from apoptotic myeloma cells to T cells: Novel method to generate specific anti-myeloma cytotoxic responses.
    Lappin, MB
    Cook, G
    Franklin, IM
    Campbell, JDM
    BLOOD, 2000, 96 (11) : 165A - 165A
  • [50] Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group
    Charlinski, Grzegorz
    Tyczynska, Agata
    Zaucha, Jan M.
    Czyz, Adriana
    Czyz, Jaroslaw
    Dytfeld, Dominik
    Malecki, Bartosz
    Gil, Lidia
    Fornagiel, Szymon
    Grosicki, Sebastian
    Barchnicka, Agnieszka
    Holojda, Jadwiga
    Kolkowska, Agnieszka
    Hus, Iwona
    Helbig, Grzegorz
    Kopinska, Anna
    Masternak, Anna
    Woszczyk, Dariusz
    Markiewicz, Miroslaw
    Piszcz, Jaroslaw
    Kloczko, Janusz
    Usnarska-Zubkiewicz, Lidia
    Wrobel, Tomasz
    Robak, Pawel J.
    Robak, Tadeusz
    Waszczuk-Gajda, Anna
    Basak, Grzegorz
    Jurczyszyn, Artur
    BLOOD, 2020, 136
12345